|
|
|
Custom, Made-to-Order Biologic Products
Bio-organic Custom APIs, Excipients and AdjuvantsComplex Technologies Novel Excipients and Adjuvants SAFC® has the capability to produce a number of high value, custom biologic products that are used as raw materials, excipients, or adjuvants for the biopharmaceutical industry. Whether it is to provide non-animal GMP reagents like our recombinant trypsin (TrypZean), using polyaminoacids and polynucleotides for uses such as adjuvants for vaccines, or excipients such as our non-animal cholesterol product, SyntheChol. SAFC Pharma® can often provide the solution for custom biologic needs that our clients have, either through our own network of facilities, or through our extensive supply chain.
| Adjuvants |
| |
Keyhole Limpet Hemocyanin (KLH): SAFC has developed a high molecular weight KLH as well as the lower molecular wight subunit. This adjuvant has been investigated for use in a number of cancer vaccines. KLH is typically conjugated to an antigen and SAFC provides conjugation services for both clinical and commercial applications |
| |
Polyarginine: SAFC is the leader in the supply of poly-l-amino acids under GMP for a myriad of drug delivery applications. Poly-l-Arginine has been used as an adjuvant in a number of infectious disease applications. |
| |
Polyinosinic acid / Polycytidilic acid (Poly I/C): Is finding it way into a growing number of vaccines for cancer, autoimmune and infectious disease. SAFC also manufactures Poly A/U for similar applications. |
| |
Lipid A: SAFC has been manufacturing Lipid A for more than 20 years for use in non-GMP research applications. This adjuvant has been investigated in a number of cancer and infectious disease vaccine applications. SAFC will be able to supply Lipid A under GMP for use in clinical and commercial applications by the end of 2009. |
| |
Contract Manufacturing: SAFC also produces a number of proprietary adjuvants on a contract basis. Please inquire |
| SAFC is also developing novel products for use in stabilizing biologic drugs and for use in targeted drug delivery applications: |
| |
recombinant HSA: is being developed as a lower cost alternative to the current recombinant HSA options being offered today. HSA is an important stabilizer for recombinant protein drugs. |
| |
Poly-l-glutamic acid and Poly-l-lysine: have found their way into a growing number of targeted drug delivery applications whereby the API is conjugated to the polyaminoacid of choic |
| |
Conjugation Services: SAFC is a leader in the conjugation of both potent and non-potent API's to a wide variety of drug delivery molecules. With separate facilities for HPAPI conjugation, SAFC is developing a leading position in the antibody drug conjugate (ADC) market. |
| Bio-organic APIs Synthesis and Purification |
SAFC Pharma also offers cGMP bio-organic synthesis and purification of bio-organic intermediates, excipients and bulk actives.
With over 30 years of experience and expertise in custom APIs scale up and manufacturing to both Pharmaceutical and Bio-pharmaceutical customers SAFC has a wide range of expertise to support customers including: |
| |
Lipids |
| |
Detergents |
| |
Buffers |
| |
Polyamino acids |
| |
Carbohydrates |
| |
Custom solvent sanitization blends |
| |
Other custom processes derived from a variety of natural and synthetic sources |
| Capabilities: |
| |
Skilled API manufacturing workforce operating 7 days per week. |
| |
cGMP compliant, multifaceted facility with fully validated equipment and Part 11 compliant distributive control system. |
| |
Design compliant with Process Safety Management guidelines to handle large quantities of flammable solvents. |
| |
Complete segregation, enclosed processing, USP Purified water, process control and HEPA-filtered air that is temperature controlled (~ 70 °F) |
| |
Manufacturing of 100 kg product quantities batches. |
| |
100, 200, and 750 gallon glass-lined reactors that can be heated to 120 °C or cooled to –20 °C |
| |
3,000 gallon crystallizer. |
| |
Vacuum filtration capacity up to 0.6 M2. |
| |
Product separation via a Peeler Centrifuge and/or large Vacuum Filter dryers up to 2.0 m2 in size. |
| |
Two large walk in hoods including 50L reactor for small scale manufacturing. |
| |
Fully validated Distributed Control System (DCS) controling and monitoring reactor's parameters, facility's utilities and USP water system. |
|
|